Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

High ductal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma.

Harkin T, Elhage O, Chandra A, Khan N, Kiberu Y, Frydenberg M, Dasgupta P.

BJU Int. 2019 May 28. doi: 10.1111/bju.14831. [Epub ahead of print]

PMID:
31136054
2.

Prognostic Significance of the Proportion of Ductal Component in Ductal Adenocarcinoma of the Prostate.

Jang WS, Shin SJ, Yoon CY, Kim MS, Kang DH, Kang YJ, Jeong WS, Cho NH, Choi YD.

J Urol. 2017 Apr;197(4):1048-1053. doi: 10.1016/j.juro.2016.11.104. Epub 2016 Dec 1.

PMID:
27916712
3.

Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.

Samaratunga H, Duffy D, Yaxley J, Delahunt B.

Hum Pathol. 2010 Feb;41(2):281-5. doi: 10.1016/j.humpath.2009.08.010. Epub 2009 Dec 11.

PMID:
20004936
5.

Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.

Gillard M, Lack J, Pontier A, Gandla D, Hatcher D, Sowalsky AG, Rodriguez-Nieves J, Vander Griend D, Paner G, VanderWeele D.

Eur Urol Focus. 2019 May;5(3):433-442. doi: 10.1016/j.euf.2017.12.003. Epub 2017 Dec 8.

6.

[Clinical Characteristics of Prostate Ductal Adenocarcinoma in Kyoto University Hospital].

Nakamura K, Terada N, Kobayashi T, Sugino Y, Yamasaki T, Matsui Y, Imamura M, Okubo K, Kamba T, Yoshimura K, Ogawa O.

Hinyokika Kiyo. 2015 Dec;61(12):487-91. Japanese.

8.

Ductal ("endometrioid") adenocarcinoma of the prostate.

Colpaert C, Gentens P, Van Marck E.

Acta Urol Belg. 1998 Dec;66(4):29-32.

PMID:
10083631
9.

Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.

Au S, Villamil CF, Alaghehbandan R, Wang G.

Ann Diagn Pathol. 2019 Apr;39:59-62. doi: 10.1016/j.anndiagpath.2019.02.007. Epub 2019 Feb 10.

PMID:
30772651
10.

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia.

Khanduri S, Imam T, Khan M, Khan S, Khan AU.

Cureus. 2019 Apr 20;11(4):e4504. doi: 10.7759/cureus.4504.

11.

Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.

Sanati S, Watson MA, Salavaggione AL, Humphrey PA.

Mod Pathol. 2009 Oct;22(10):1273-9. doi: 10.1038/modpathol.2009.103. Epub 2009 Jul 24.

12.

Spectrum of Cystic Epithelial Tumors of the Prostate: Most Cystadenocarcinomas Are Ductal Type With Intracystic Papillary Pattern.

Paner GP, Lopez-Beltran A, So JS, Antic T, Tsuzuki T, McKenney JK.

Am J Surg Pathol. 2016 Jul;40(7):886-95. doi: 10.1097/PAS.0000000000000618.

PMID:
26900818
13.

Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy.

Tu SM, Lopez A, Leibovici D, Bilen MA, Evliyaoglu F, Aparicio A, Guo CC, Kuban DA, Johnson MM, Pisters LL.

Cancer. 2009 Jul 1;115(13):2872-80. doi: 10.1002/cncr.24326.

14.

TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.

Lotan TL, Toubaji A, Albadine R, Latour M, Herawi M, Meeker AK, DeMarzo AM, Platz EA, Epstein JI, Netto GJ.

Mod Pathol. 2009 Mar;22(3):359-65. doi: 10.1038/modpathol.2008.236. Epub 2009 Jan 16.

15.

Cystic prostatic ductal adenocarcinoma: an unusual presentation and cytological diagnosis.

Henderson-Jackson E, Sexton W, Zhang J, Hakam A, Petrovskyy VS, Bui MM, Chuang ST.

Ann Clin Lab Sci. 2012 Winter;42(1):81-8.

PMID:
22371914
16.

PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.

Morais CL, Herawi M, Toubaji A, Albadine R, Hicks J, Netto GJ, De Marzo AM, Epstein JI, Lotan TL.

Prostate. 2015 Oct;75(14):1610-9. doi: 10.1002/pros.23042. Epub 2015 Jul 14.

17.

Ductal and Acinar Adenocarcinoma of Prostate: Morphological and Immunohistochemical Characterization.

Baig FA, Hamid A, Mirza T, Syed S.

Oman Med J. 2015 May;30(3):162-6. doi: 10.5001/omj.2015.36.

18.

Ductal Carcinoma of the Prostate: An Uncommon Entity With Atypical Behaviour.

Bergamin S, Eade T, Kneebone A, Kench JG, Sved P, Biset JF, Hruby G.

Clin Oncol (R Coll Radiol). 2019 Feb;31(2):108-114. doi: 10.1016/j.clon.2018.10.011. Epub 2018 Nov 22.

PMID:
30471806
19.

Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.

Kim A, Kwon T, You D, Jeong IG, Go H, Cho YM, Hong JH, Ahn H, Kim CS.

J Korean Med Sci. 2015 Apr;30(4):385-9. doi: 10.3346/jkms.2015.30.4.385. Epub 2015 Mar 19.

20.

Supplemental Content

Support Center